… 2020 for the literature on COVID-19 in RMD patients as … rheumatic disease”, “inflammatory
arthritis”, “rheumatic and musculoskeletal diseases” in various combinations with “COVID-19…

… rheumatic diseases as well as other autoimmune diseases and transplants will pose difficult
questions. This article is an attempt to review and understand COVID-19 … rheumatic diseases…

… After its emergence in December 2019 in Wuhan, China, the COVID-19 outbreak has now …
of COVID-19 among patients with rheumatic diseases treated with biologic disease- modifying …

… rheumatic diseases, are at increased risk of infection, including by SARS-CoV-2.The prevalence
of COVID-19 and its association with rheumatic diseases … prevalence of COVID-19 in …

… -19 immune responses, we aim to describe some of the … in rheumatic diseases and COVID-19.
We also aim to summarise the risk of developing severe COVID-19 in rheumatic disease …

… immune diseases, thus accounting for 0.88% of the total confirmed COVID-19 patients …
may underestimate the incidence of rheumatic diseases in patients with COVID-19. It may be …

… -modifying antirheumatic drugs (bDMARDs) does not associate with severe manifestations
of COVID-19. Patients with rheumatic disease diagnosed with COVID-19 were more likely to …

… rheumatic diseases and COVID-19 infection. Articles were initially selected by their title and
abstract and then the full text was searched for the appropriate relevant content. References …

… Notably, however, this analysis was based on a low number of people with rheumatic disease
and COVID-19 diagnoses, resulting in a wide confidence interval. In a multicentre study of …

… Overall, the prognosis of patients with rheumatic diseases hospitalized with COVID-19 is …
Studies including inflammatory rheumatic disease patients with COVID-19 are still limited; …